What is the first line of treatment for a 30-year-old woman with heavy and prolonged menstrual bleeding (menorrhagia) lasting 15 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Heavy and Prolonged Menstrual Bleeding

NSAIDs (such as ibuprofen 400 mg every 4-6 hours or naproxen) prescribed for 5-7 days during active bleeding days are the recommended first-line pharmacologic treatment for this 30-year-old woman with heavy menstrual bleeding. 1, 2

Immediate Assessment Required

Before initiating treatment, you must:

  • Rule out pregnancy immediately with a urine or serum pregnancy test, as this is mandatory in all reproductive-age women with abnormal bleeding 1, 2
  • Assess hemodynamic stability by checking vital signs, orthostatic changes, and signs of acute blood loss 2
  • Evaluate for structural causes including fibroids, polyps, adenomyosis, or endometrial pathology through pelvic examination and consider pelvic ultrasound if clinically indicated 1
  • Screen for coagulopathies if there is a personal or family history of bleeding disorders, as up to 20% of women with heavy menstrual bleeding may have an underlying inherited bleeding disorder 1, 2

First-Line Treatment: NSAIDs

NSAIDs are the appropriate initial pharmacologic choice because they:

  • Reduce menstrual blood loss by 25-35% through prostaglandin synthetase inhibition 1, 2, 3
  • Are prescribed only during the 5-7 days of active bleeding, not continuously 1, 2
  • Multiple agents are effective: mefenamic acid, naproxen, indomethacin, flufenamic acid, and diclofenac sodium 1
  • For ibuprofen specifically: 400 mg every 4-6 hours as needed during menstruation (do not exceed 3200 mg daily) 4

Critical Contraindications to NSAIDs

You must screen for and avoid NSAIDs in women with:

  • Cardiovascular disease (increased risk of myocardial infarction and thrombosis) 1
  • Active peptic ulcer disease or history of gastrointestinal bleeding 4
  • Renal impairment 4
  • Never use aspirin, as it does not reduce bleeding and may actually increase blood loss 1

If NSAIDs Fail After 1-3 Cycles

Second-line options include:

  1. Levonorgestrel-releasing intrauterine device (LNG-IUD) - the most effective medical treatment, reducing menstrual blood loss by 71-95% 1, 2, 5, 6, 7

  2. Tranexamic acid - a non-hormonal alternative reducing blood loss by approximately 80 mL per cycle, but absolutely contraindicated in women with active thromboembolic disease, history of thrombosis, or cardiovascular disease 1, 2, 5

  3. Combined hormonal contraceptives (oral or vaginal ring) - effective for reducing menstrual blood loss when hormonal options are appropriate 5, 7

Treatment Algorithm

Start with NSAIDs for 5-7 days during bleeding 1, 2Reassess after 1-3 menstrual cycles 2If bleeding persists or remains unacceptable:

  • Consider LNG-IUD if patient desires long-term contraception or definitive management 1, 5
  • Consider tranexamic acid if hormonal options are contraindicated 1, 2
  • Consider combined hormonal contraceptives if patient desires contraception 5If medical management fails, refer for evaluation of surgical options 2

Important Counseling Points

  • Enhanced counseling about expected bleeding patterns and reassurance that initial irregularities with certain treatments (especially LNG-IUD) can improve treatment adherence 1, 2
  • NSAIDs should be taken with food or milk to minimize gastrointestinal side effects 4
  • The LNG-IUD may cause irregular bleeding initially but often leads to light bleeding or amenorrhea over time 1

References

Guideline

Treatment of Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Assessment of medical treatments for menorrhagia.

British journal of obstetrics and gynaecology, 1994

Guideline

Treatment Options for Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.